Practical insights on compliance, retention, eCOA/ePRO, wearables, and trial operations—pulled directly from our blog library.
Continuous, real-world data collection. Wearables change clinical trials from snapshot-based in-clinic measurements to longitudinal physiologic visibility — and shift compliance from a reporting problem to an operational one.
Continuous, real-time signal capture lets clinicians and study teams detect deterioration earlier, intervene faster, and document physiology in a way episodic visits never could.
Dropouts are not random — they’re the downstream result of operational gaps. Reminder logic, multilingual support, and proactive concierge follow-up convert silent drift into recoverable signal.
A trained, multilingual concierge layer removes the barriers — scheduling, transport, language, device confusion — that drive non-compliance and dropouts in real-world trials.
Patient-centricity is no longer aspirational. Modern ePRO and eCOA design choices — burden, language, accessibility, and feedback — are now the difference between completion and attrition.
ePRO and eCOA platforms succeed when they’re designed around patients, not protocols. The right multilingual workflows, adaptive logic, and accessibility built in from day one move compliance into the 90s.
Compliance + retention = ROI. Quantifying the financial impact of ePRO/eCOA at the protocol level reframes the conversation from cost-center to investment in evidence quality.
Decentralized trials demand more from eCOA — the workflow has to keep working when there is no site visit to bail it out. That makes execution discipline, not software features, the dominant variable.
From discrete in-clinic measurements to continuous physiologic signal. Wearables don’t just produce more data — they change what trials can claim and what regulators will accept as evidence.